AbbVie (NYSE:ABBV) Given Neutral Rating at The Goldman Sachs Group
The Goldman Sachs Group reiterated their neutral rating on shares of AbbVie (NYSE:ABBV – Free Report) in a report published on Tuesday, Marketbeat.com reports. They currently have a $194.00 price objective on the stock. A number of other research firms also recently weighed in on ABBV. Erste Group Bank upgraded shares of AbbVie to a […]
The Goldman Sachs Group reiterated their neutral rating on shares of AbbVie (NYSE:ABBV – Free Report) in a report published on Tuesday, Marketbeat.com reports. They currently have a $194.00 price objective on the stock. A number of other research firms also recently weighed in on ABBV. Erste Group Bank upgraded shares of AbbVie to a […]